VNVALUEVNVALUE
Updated weekly
Back to Dashboard
Consumer sector

HJC

Consumer
Công ty Cổ phần Hoà Việt
Hàng cá nhân & Gia dụng/Thuốc láCT
7.000
VND · Last close
Valuation Verdict
Undervalued
Low
-120%Fair Value+120%
Intrinsic Value
8.416
Current
7.000
Gap
+20.2%
ModelFCF DCF

Valuation Breakdown

CTHàng cá nhân & Gia dụngConsumer
Classified as consumer because ICB sector "Hàng cá nhân & Gia dụng" maps to the consumer group
ModelFCF-Based DCF
Value = Sum of [FCF / (1+WACC)^t] + Terminal Value / (1+WACC)^n

A classic Discounted Cash Flow model built on Free Cash Flow (FCF), the actual cash a business generates after all operating expenses and capital expenditures. Future FCF is projected for 10 years with gradually decaying growth, then discounted back to today's value using WACC. This is the gold standard of intrinsic valuation: it values the company based on what it can actually deliver to shareholders, independent of market sentiment.

1
Weighted Avg Cost of Capital
Risk-Free (Rf)
4.50%
+
Betasector default
0.800
x
ERP
4.25%
+
CRP
2.75%
=
Cost of Equity (Ke)
10.10%
Ke
10.10%
x
E/(D+E)
57.46%
+
Kd(1-t)
6.26%
x
D/(D+E)
42.54%
=
WACC
10.00%
2
Growth Estimate
fundamental firm blend4.55%
Growth decays 10%/yr toward terminal
3
Model Inputs
Base FCF12.71B
Projection years10
4
Valuation
Base FCF
12.71B
Growth Rate
4.55%
WACC
10.00%
Terminal Growth
4.00%
DCF Value
8.416
Value Decomposition
43%
57%
Explicit period (43%)Terminal value (57%)

Valuation Track Record

Retroactive intrinsic value vs actual close price — HJC

Earnings Quality

Fiscal year 2025

57
Fair
Accrual Quality
55
Cash Conversion
0
Receivables
100
Margin Stability
100
Revenue Quality
52

Financial Forensics

Beneish M-Score · 2025

-1.25
High Risk
DSRI
1.839
GMI
0.918
AQI
0.678
SGI
1.270
DEPI
1.029
SGAI
1.041
TATA
0.118
LVGI
1.491

HJC exhibits several concerning financial metrics that suggest potential earnings manipulation, particularly indicated by a Beneish M-Score of -1.2518, which is above the manipulation threshold of -1.78. The earnings quality score of 56.6/100, alongside a notably low cash conversion score of 0.0/100, raises further concerns about the sustainability of reported earnings.

Red Flags
  • Beneish M-Score of -1.2518, indicating potential earnings manipulation risk as it is above the threshold of -1.78.
  • Earnings quality cash conversion score of 0.0/100, suggesting severe issues with converting earnings into cash.
  • DSRI of 1.8393, indicating a significant increase in receivables relative to sales, which may signal aggressive revenue recognition.
Positive Signals
  • Receivables quality score of 100.0/100, indicating strong management of receivables.
  • SGI of 1.2705, suggesting that HJC is experiencing sales growth, which could be a positive indicator if supported by cash flow.
Ownership Risk

The ownership structure is heavily concentrated, with Tổng Công ty Thuốc lá Việt Nam holding 76.1%, which may lead to governance risks and limit minority shareholder influence. This concentration can lead to decisions that prioritize the interests of the majority shareholder over minority shareholders.

Recommendation

Investors should exercise caution and conduct further due diligence on HJC, particularly focusing on cash flow statements and revenue recognition practices. Monitoring future earnings reports for improvements in cash conversion and overall earnings quality is essential.

Generated by AI based on quantitative data. Not financial advice.

Quantitative Scores

F-Score
2/9
Weak
Z-Score
2.81
Grey Zone
Sharpe
0.09
Positive
Composite
60
Fair
Price Risk
Momentum
+20.9%
Volatility
87.5%
Max Drawdown
-42.0%

Key Ratios

Fiscal year 2025
5.70P/E
P/B0.51
P/S0.09
ROE9.2%
ROA4.1%
EPS1332.21
BVPS14926.71
Gross Margin11.0%
Net Margin1.6%
D/E1.73
Current Ratio1.42
Rev Growth27.0%
Profit Growth34.7%
EV/EBITDA5.71
Div Yield0.0%

Company Overview

Issued Shares
12.9M
Charter Capital
128.5B VND
Sector (ICB L2)
Hàng cá nhân & Gia dụng
Industry (ICB L3)
Thuốc lá
Sub-industry
Thuốc lá
Company Type
CT

// OWNERSHIP_NETWORK

> mapping common ownership for HJC — hover nodes for intel, click to navigate

Shareholders
Tổng Công ty Thuốc lá Việt Nam
Inst
76.1%
9.8 trieu
Công ty TNHH MTV Thuốc lá Sài Gòn
Inst
6.5%
838.738
Công ty TNHH Một thành viên Thuốc lá Thăng Long
Inst
2.8%
359.459
Nguyễn Diệu Hương
Indiv
0.3%
32.152
Nguyễn Đức Lượng
Indiv
0.2%
21.806
Board & Management
Nguyễn Diệu Hương0.3%
Thành viên Hội đồng Quản trị
Nguyễn Đức Lượng0.2%
Phó Giám đốc
Đào Xuân Lập
Trưởng Ban kiểm soát
Nguyễn Thị Thành
Kế toán trưởng
Lương Hữu Hưng
Giám đốc/Thành viên Hội đồng Quản trị
Phan Quốc Toàn
Phó Giám đốc/Thành viên Hội đồng Quản trị
Châu Tuấn
Chủ tịch Hội đồng Quản trị
Đinh Tiến Lộc
Thành viên Hội đồng Quản trị
Nguyễn Nguyên Quốc Vũ
Trưởng phòng Tài chính - Kế toán/Phụ trách Công bố thông tin
Nguyễn Hữu Hồng Sơn
Thành viên Ban kiểm soát
Lê Hoàn Vũ
Thành viên Ban kiểm soát
Computed 12/04/2026
Methodology & Disclosure

vnvalue is a methodology engine — not an advisor. Every number is the deterministic output of a published formula applied to public financial data. Nothing on this page constitutes investment, financial, legal, or tax advice, nor a recommendation to buy, sell, or hold any security.

All data, models, and outputs are provided AS IS without warranty of any kind. You are solely responsible for your investment decisions. Past performance and historical valuations are not indicative of future results.

By using vnvalue you accept the Terms of Service and Privacy Policy. Full disclaimer →